Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone
Stefano de Biase,1 Mariarosaria Valente,1,2 Gian Luigi Gigli1,21Neurology Unit, Department of Experimental and Clinical Medical Sciences, University of Udine Medical School, 2Department of Neurosciences, Santa Maria della Misericordia University Hospital, Udine, ItalyAbstract: Restless legs syndrome...
Enregistré dans:
Auteurs principaux: | de Biase S, Valente M, Gigli GL |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/dc949b9b5cc94a8facd797f64a976ef7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation
par: Lazzari M, et autres
Publié: (2016) -
Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study
par: Petrò E, et autres
Publié: (2016) -
Is oxycodone/naloxone effective and safe in managing chronic pain of a fragile elderly patient with multiple skin ulcers of the lower limbs? A case report
par: Guerriero F, et autres
Publié: (2015) -
The Safety and Efficacy of Pregabalin Add-on Therapy in Restless Legs Syndrome Patients
par: Hyoeun Bae, et autres
Publié: (2021) -
Effectiveness and safety of oxycodone/naloxone in the management of chronic pain in patients with systemic sclerosis with recurrent digital ulcers: two case reports
par: Ughi N, et autres
Publié: (2016)